Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection
Authors
Keywords
Gastric cancer, Programmed cell death 1, Programmed cell death ligand 1
Journal
Gastric Cancer
Volume 19, Issue 2, Pages 466-471
Publisher
Springer Nature
Online
2015-07-25
DOI
10.1007/s10120-015-0519-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer
- (2015) Yaxiong Zhang et al. MEDICINE
- PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients
- (2014) Shenyou Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
- (2014) Jin Won Kim et al. Gastric Cancer
- Human hepatocellular carcinoma-infiltrating CD4+CD69+Foxp3− regulatory T cell suppresses T cell response via membrane-bound TGF-β1
- (2014) Yanmei Han et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma
- (2014) Matthew J. Ahearne et al. VIRCHOWS ARCHIV
- The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
- (2013) S. Muenst et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities
- (2013) Barbara Merelli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+tumor infiltrating lymphocytes in ductal and lobular breast cancers
- (2012) Raoul Droeser et al. BMC CANCER
- The role of FOXP3 in the development and metastatic spread of breast cancer
- (2012) Stephen Douglass et al. CANCER AND METASTASIS REVIEWS
- High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer
- (2012) Anna Flammiger et al. EUROPEAN JOURNAL OF CANCER
- Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+regulatory T cells
- (2012) Sheetal Bodhankar et al. IMMUNOLOGY
- Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer
- (2012) Hiroaki Saito et al. JOURNAL OF SURGICAL ONCOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunoregulatory Molecule B7-H1 (CD274) Contributes to Skin Carcinogenesis
- (2011) Y. Cao et al. CANCER RESEARCH
- Japanese classification of gastric carcinoma: 3rd English edition
- (2011) Gastric Cancer
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started